Publications: Dr Corinna Pade
Astbury S, Reynolds CJ, Butler DK, Muñoz-Sandoval DC, Lin KM, Pieper FP, Otter A, Kouraki A et al.
(
2022
)
.
HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19
.
Immunology
vol.
166
,
(
1
)
68
-
77
.
Chandran A, Rosenheim J, Nageswaran G, Swadling L, Pollara G, Gupta RK, Burton AR, Guerra-Assunção JA et al.
(
2022
)
.
Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections
.
Cell Reports Medicine
vol.
3
,
(
3
)
Reynolds CJ, Gibbons JM, Pade C, Lin KM, Sandoval DM, Pieper F, Butler DK, Liu S et al.
(
2022
)
.
Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants
.
Science
vol.
375
,
(
6577
)
183
-
192
.
Usai C, Gibbons JM, Pade C, Li W, Jacobs SRM, McKnight A, Kennedy PTF, Gill US
(
2022
)
.
The β-NGF/TrkA Signalling Pathway Is Associated With the Production of Anti-Nucleoprotein IgG in Convalescent COVID-19
.
Frontiers in Immunology
vol.
12
,
Mcknight A, Pade C, Gibbons J
(
2021
)
.
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
.
Nature
Gupta RK, Rosenheim J, Bell LC, Chandran A, Guerra-Assuncao JA, Pollara G, Whelan M, Artico J et al.
(
2021
)
.
Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study
.
Lancet Microbe
vol.
2
,
(
10
)
e508
-
e517
.
Swadling L, Diniz M, Schmidt N, Amin O, Chandran A, Shaw E, Pade C, Gibbons J et al.
(
2021
)
.
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 infection
.
Reynolds CJ, Pade C, Gibbons JM, Butler DK, Otter AD, Menacho K, Fontana M, Smit A et al.
(
2021
)
.
Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
.
Science
vol.
372
,
(
6549
)
1418
-
1423
.
Manisty C, Treibel TA, Jensen M, Semper A, Joy G, Gupta RK, Cutino-Moguel T, Andiapen M et al.
(
2021
)
.
Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection
.
EBioMedicine
vol.
65
,
Reynolds CJ, Swadling L, Gibbons JM, Pade C, Jensen MP, Diniz MO, Schmidt NM, Butler DK et al.
(
2020
)
.
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
.
Science Immunology
vol.
5
,
(
54
)
Manisty C, Treibel TA, Jensen M, Semper A, Joy G, Gupta RK, Cutino-Moguel T, Andiapen M et al.
(
2020
)
.
Characterising heterogeneity and sero-reversion in antibody responses to mild SARS⍰CoV-2 infection: a cohort study using time series analysis and mechanistic modelling
.
Treibel TA, Manisty C, Andiapen M, Pade C, Jensen M, Fontana M, Couto-Parada X, Cutino-Moguel T et al.
(
2020
)
.
Asymptomatic health-care worker screening during the COVID-19 pandemic – Authors' reply
.
The Lancet
vol.
396
,
(
10260
)
1394
-
1395
.
Reynolds C, Swadling L, Gibbons J, Pade C, Jensen M, Diniz M, Schmidt N, Butler D et al.
(
2020
)
.
Healthcare workers with mild / asymptomatic SARS-CoV-2 infection show T cell responses and neutralising antibodies after the first wave
.
Augusto JB, Menacho K, Andiapen M, Bowles R, Burton M, Welch S, Bhuva AN, Seraphim A et al.
(
2020
)
.
Healthcare Workers Bioresource: Study outline and baseline characteristics of a prospective healthcare worker cohort to study immune protection and pathogenesis in COVID-19
.
Wellcome Open Research
vol.
5
,
179
-
179
.
Dreja H, Pade C, Chen L, McKnight Á
(
2015
)
.
CD4 binding site broadly neutralizing antibody selection of HIV-1 escape mutants
.
Journal of General Virology
vol.
96
,
(
7
)
1899
-
1905
.
Marno KM, Ogunkolade BW, Pade C, Oliveira NMM, O'Sullivan E, McKnight A
(
2014
)
.
Novel restriction factor RNA-associated early-stage anti-viral factor (REAF) inhibits human and simian immunodeficiency viruses
.
Retrovirology
vol.
11
,
(
1
)
Marno K, Ogunkolade B, Pade C, Oliveira N, O’Sullivan E, McKnight Á
(
2013
)
.
Novel restriction factor RNA-associated early-stage anti-viral factor (REAF) inhibits human and simian immunodeficiency viruses
.
Retrovirology
vol.
10
,
(
Suppl 1
)
Liu L, Oliveira NMM, Cheney KM, Pade C, Dreja H, Bergin A-MH, Borgdorff V, Beach DH et al.
(
2011
)
.
A whole genome screen for HIV restriction factors
.
Retrovirology
vol.
8
,
Dreja H, O'Sullivan E, Pade C, Greene KM, Gao H, Aubin K, Hand J, Isaksen A et al.
(
2010
)
.
Neutralization activity in a geographically diverse East London cohort of human immunodeficiency virus type 1-infected patients: clade C infection results in a stronger and broader humoral immune response than clade B infection
.
J Gen Virol
vol.
91
,
(
Pt 11
)
2794
-
2803
.
Corti D, Langedijk JPM, Hinz A, Seaman MS, Vanzetta F, Fernandez-Rodriguez BM, Silacci C, Pinna D et al.
(
2010
)
.
Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals
.
PLOS ONE
vol.
5
,
(
1
)
Article
e8805
,
Dreja H, O'Sullivan E, Pade C, Aubin K, Isaksen A, D'Souza C, Hand J, Orkin C et al.
(
2009
)
.
Neutralisation activity in a geographically diverse East London cohort of HIV-1 infected patients
.
RETROVIROLOGY
vol.
6
,
Article
P63
,
Corti D, Pinna D, Vanzetta F, Balla S, Dreja H, O'Sullivan E, Pade C, Hinz A et al.
(
2008
)
.
A Panel of HIV-1 Neutralizing Antibodies Isolated from Non-clade B HIV-1 Infected Donors
.
AIDS RESEARCH AND HUMAN RETROVIRUSES
.
vol.
24
,
3
-
3
.
Machín F, Paschos K, Jarmuz A, Torres-Rosell J, Pade C, Aragón L
(
2004
)
.
Condensin regulates rDNA silencing by modulating nucleolar Sir2p
.
Curr Biol
vol.
14
,
(
2
)
125
-
130
.